An editorial is presented on impact of CFTR modulatory therapy on airway epithelial health in cystic fibrosis (CF) patients and unveils underlying epithelial and immune dysfunction. Topics include effectiveness of CFTR modulation, insights into epithelial and immune cell alterations, and implications for future therapeutic strategies.